在3小时口服葡萄糖耐受性测试中的一个异常值与双胞胎妊娠中的不良周产期结果之间的关联
Tzuria Peled1, Hen Y Sela1, Ari Weiss1
1Department of Obstetrics & Gynecology, Shaare Zedek Medical Center, Affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.
Diabetes research and clinical practice
|July 1, 2023
概括
双胞胎妊娠和一个异常口服葡萄糖耐受性测试 (OGTT) 结果的妇女面临更高的新生儿不良结果的风险,包括早产和新生儿发病率. 需要进一步的研究来探索对这一高风险群体的干预措施.
科学领域:
- 周围生理学 周围生理学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 内分泌学 在内分泌学.
背景情况:
- 双胞胎怀孕与不良周产期结果的风险增加有关.
- 妊娠期糖尿病 (GDM) 查对于识别风险妊娠至关重要.
- 边界异常葡萄糖耐受性测试结果在双胞胎怀孕中的意义需要进一步调查.
研究的目的:
- 评估双胞胎怀孕与一个异常的3小时口服葡萄糖耐受性测试 (OGTT) 值和不良周产期结果之间的关联.
- 为了在不同OGTT结果类别中比较双胞胎妊娠的女性的结果.
主要方法:
- 这是一项回顾性多中心研究,涉及2597名双胞胎妊娠的妇女.
- 四组的比较:正常的屏幕,正常的3小时OGTT,一个异常的3小时OGTT和GDM.
- 多变量逻辑回归分析,以关键混因素进行调整.
主要成果:
- 具有一个异常OGTT值的女性显示出显著更高的早产率 (<32周) 和孕期新生儿的大.
- 复合新生儿发病率更频繁地发生在来自母亲的一个异常OGTT值的新生儿中.
- 具有一个异常OGTT值的女性和具有正常屏幕的女性之间,母亲的结果是相似的.
结论:
- 双胞胎怀孕中有一个异常的3小时OGTT值与不良新生儿结果的风险增加有关.
- 这些发现突出了双胞胎怀孕中的特定高风险组,需要进一步关注.
- 干预研究是有必要的,以确定管理策略是否可以改善这一群体的围产期结果.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Glucose Transporters
23.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.3K
Diabetes: Symptoms, Diagnosis, and Complications
603
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
603
Oral Hypoglycemic Agents: Biguanides and Glitazones
238
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
238
Hypoglycemia and Glucagon
305
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
305


